<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01431235</url>
  </required_header>
  <id_info>
    <org_study_id>10-130</org_study_id>
    <nct_id>NCT01431235</nct_id>
  </id_info>
  <brief_title>CBT for Patients With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders</brief_title>
  <official_title>Investigating the Efficacy of Cognitive Behavioral Therapy in Patients With Substance Use Disorder and Comorbid ADHD. A Randomized Controlled Trial With Cognitive Behavioral Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arkin</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fonds NutsOhra</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Arkin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if cognitive behavioral therapy is effective in
      treating ADHD symptoms in patients with substance use disorders and comorbid ADHD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Attention Deficit Hyperactivity Disorder(ADHD) is an important comorbid condition in patients
      with substance use disorders (SUD). The prevalence of ADHD in patients with SUD is estimated
      23%, and ADHD is associated with an untoward prognosis of SUD. However, adequate treatment
      programs for patients with ADHD and SUD are not available. Results of medication trials for
      patients with ADHD and SUD are disappointing, and cognitive behavioral therapy (CBT) has not
      yet been investigated in this population. In patients with ADHD without comorbid SUD, the
      results of CBT in randomized trials are positive. The purpose of this study is to investigate
      if CBT is effective in treating ADHD symptoms in patients with ADHD and SUD.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>self reported ADHD symptoms</measure>
    <time_frame>6 months</time_frame>
    <description>Dutch self report list of ADHD symptoms by Kooij and Buitelaar</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time Line Follow Back method</measure>
    <time_frame>6 months</time_frame>
    <description>self-reported alcohol and drug use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck depression inventory</measure>
    <time_frame>6 months</time_frame>
    <description>self reported depression symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Anxiety Inventory</measure>
    <time_frame>6 months</time_frame>
    <description>Self reported anxiety symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5</measure>
    <time_frame>6 months</time_frame>
    <description>Self reported quality of living</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TIC-P</measure>
    <time_frame>6 months</time_frame>
    <description>health care consumption and production loss in relation to mental health problems</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroop task</measure>
    <time_frame>6 months</time_frame>
    <description>neuropsychological measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tower of London task</measure>
    <time_frame>6 months</time_frame>
    <description>neuropsychological task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BART task</measure>
    <time_frame>6 months</time_frame>
    <description>neuropsychological task on risk taking behavior</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urine checks</measure>
    <time_frame>6 months</time_frame>
    <description>urine checks on drug use</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">184</enrollment>
  <condition>Attention Deficit Hyperactivity Disorder</condition>
  <condition>Substance Use Disorders</condition>
  <arm_group>
    <arm_group_label>standard addiction treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>10 sessions of standard addiction treatment. No ADHD treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>addiction treatment and ADHD treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 sessions cognitive behavioral therapy on addiction treatment combined with 5 sessions on ADHD treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>cognitive behavioral therapy for treating ADHD symptoms</intervention_name>
    <description>5 sessions of one hour CBT for treating ADHD symptoms by a trained health care worker</description>
    <arm_group_label>addiction treatment and ADHD treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  substance use disorder

          -  ADHD

          -  able to comply with study activities

        Exclusion Criteria:

          -  severe neurological or psychiatric diseases (for example Parkinson, dementia,
             psychosis, bipolar depression) which require medication

          -  unable to read or write Dutch language
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Schoevers, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Groningen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arkin</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Arias AJ, Gelernter J, Chan G, Weiss RD, Brady KT, Farrer L, Kranzler HR. Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav. 2008 Sep;33(9):1199-207. doi: 10.1016/j.addbeh.2008.05.003. Epub 2008 May 13.</citation>
    <PMID>18558465</PMID>
  </reference>
  <reference>
    <citation>Castells X, Ramos-Quiroga JA, Rigau D, Bosch R, Nogueira M, Vidal X, Casas M. Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis. CNS Drugs. 2011 Feb;25(2):157-69. doi: 10.2165/11539440-000000000-00000.</citation>
    <PMID>21254791</PMID>
  </reference>
  <reference>
    <citation>Safren SA, Sprich S, Mimiaga MJ, Surman C, Knouse L, Groves M, Otto MW. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA. 2010 Aug 25;304(8):875-80. doi: 10.1001/jama.2010.1192.</citation>
    <PMID>20736471</PMID>
  </reference>
  <reference>
    <citation>Solanto MV, Marks DJ, Wasserstein J, Mitchell K, Abikoff H, Alvir JM, Kofman MD. Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry. 2010 Aug;167(8):958-68. doi: 10.1176/appi.ajp.2009.09081123. Epub 2010 Mar 15.</citation>
    <PMID>20231319</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2011</study_first_submitted>
  <study_first_submitted_qc>September 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2011</study_first_posted>
  <last_update_submitted>January 13, 2017</last_update_submitted>
  <last_update_submitted_qc>January 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ADHD</keyword>
  <keyword>SUD</keyword>
  <keyword>cognitive behavioral therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
    <mesh_term>Hyperkinesis</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

